It's not necessarily nonetheless obvious how to manage possible FDA approval of psychedelics inside the context of ongoing DEA Agenda I classification.20 Additionally, it can be unclear how the healthcare program would put into action copyright remedy, which can be a remarkable departure from available professional medical and behavioral therapies